Drug firm AstraZeneca doubles coronavirus vaccine manufacturing capacity

Drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to two billion doses in a handful of deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries.
Drug firm AstraZeneca doubles coronavirus vaccine manufacturing capacity

Drugmaker AstraZeneca has doubled manufacturing capacity for its potential coronavirus vaccine to two billion doses in a handful of deals involving Microsoft billionaire Bill Gates that guarantee early supply to lower income countries.

The deals with epidemic response group CEPI and vaccine alliance GAVI are backed by the World Health Organisation and aim to quell concerns that the company was committing all initial supplies of the vaccine to the developed world.

It is unclear if vaccines will work against the coronavirus but dozens of companies are in the race to develop one, and AstraZeneca’s partnership with Oxford University is one of a handful to be backed so far by US President Donald Trump’s COVID task force.

Under the deals, the company will supply 300 million doses, starting this year, to CEPI and GAVI as it aims at fair and equitable distribution of the vaccine, CEO Pascal Soriot said.

He said AstraZeneca had also agreed terms with Serum Institute of India, the world’s largest manufacturer of vaccines by volume, to supply one billion doses for low and middle-income countries.

Experts predict a safe and effective vaccine could take 12-18 months to develop.

The vaccine, previously known as ChAdOx1 nCoV-19, was developed by the University of Oxford and licensed to AstraZeneca.

- Reuters

more articles

Leo Varadkar still has ‘some’ texts from pandemic period Leo Varadkar still has ‘some’ texts from pandemic period
Taoiseach visit to the US Leo Varadkar still has ‘some’ texts from covid pandemic period
Nolan says lessons need to be learned from Covid inquiry Nolan says lessons need to be learned from Covid inquiry

More in this section

FILE PHOTO The Competition and Consumer Protection Commission has cleared the purchase of Goodbody Stockbrokers by AIB END Goodbody Stockbrokers fined over €1.2m by Central Bank over rules breaches
Nottingham City Centre Stock Irish staff at the Body Shop wait for wages as retailer shuts stores in the Republic
Ryanair comments on Norwegian Ryanair boss O'Leary's spat with Transport Minister over Dublin Airport escalates
IE logo
Devices


UNLIMITED ACCESS TO THE IRISH EXAMINER FOR TEAMS AND ORGANISATIONS
FIND OUT MORE

The Business Hub
Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Sign up
ie logo
Puzzles Logo

Play digital puzzles like crosswords, sudoku and a variety of word games including the popular Word Wheel

Lunchtime News
Newsletter

Keep up with the stories of the day with our lunchtime news wrap.

Sign up
Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited